Melatonin is synthesized by the pineal gland and regulates the body's sleep-wake cycle. Though commonly recognized as the "sleep hormone," this compound increases at night and correlates with sleep quality. Beyond its sleep-promoting properties, melatonin demonstrates lesser-known analgesic capabilities that merit scientific attention.
The precise mechanisms underlying melatonin's pain-relieving effects remain incompletely understood. Research suggests receptors in the nervous system may bind melatonin to block pain signals from reaching the brain. Additionally, melatonin appears to interfere with ion channels necessary for nerve impulse transmission, with one study demonstrating its ability to inhibit stress-related abdominal pain through calcium channel interaction.
Clinical evidence establishes melatonin's effectiveness across diverse pain conditions. Daily supplementation reduces chronic inflammatory pain associated with fibromyalgia and irritable bowel syndrome. Research on spinal intervertebral disc cells suggests potential therapeutic applications for degenerative disc conditions.
Melatonin shows particular promise for headache management. Since headaches and sleep disturbances are interconnected, melatonin's dual functionality becomes therapeutically valuable. Research indicates 78.6% of patients experienced headache relief with regular supplementation. A clinical trial demonstrated that 3 mg doses administered before bedtime reduced migraine intensity, frequency, and duration effectively.
Given melatonin's lack of adverse effects, researchers propose its perioperative use to reduce patient anxiety and post-operative pain, warranting further investigation into its multiple therapeutic applications.